Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
6.98
+0.01 (0.14%)
At close: May 12, 2025, 4:00 PM
6.85
-0.13 (-1.85%)
After-hours: May 12, 2025, 4:00 PM EDT

Lifecore Biomedical Revenue

Lifecore Biomedical had revenue of $35.15M in the quarter ending February 23, 2025, a decrease of -1.54%. This brings the company's revenue in the last twelve months to $130.31M, up 7.23% year-over-year. In the fiscal year ending May 26, 2024, Lifecore Biomedical had annual revenue of $128.26M with 24.20% growth.

Revenue (ttm)
$130.31M
Revenue Growth
+7.23%
P/S Ratio
1.78
Revenue / Employee
$248,681
Employees
524
Market Cap
258.44M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
May 26, 2024128.26M24.99M24.20%
May 28, 2023103.27M-8.00M-7.19%
May 29, 2022111.27M10.40M10.31%
May 30, 2021100.87M-59.19M-36.98%
May 31, 2020160.07M-397.49M-71.29%
May 26, 2019 Pro Pro Pro
May 27, 2018 Pro Pro Pro
May 28, 2017 Pro Pro Pro
May 29, 2016 Pro Pro Pro
May 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 410.06B
Johnson & Johnson 89.33B
Merck & Co. 63.92B
AbbVie 57.37B
AstraZeneca 54.98B
Novartis AG 53.22B
Eli Lilly and Company 49.00B
Novo Nordisk 43.92B
Revenue Rankings